Survival adjusting for crossover: Phase 3 study of ibrutinib vs. chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma
- Steven Coutre
- , Alessandra Tedeschi
- , Tadeusz Robak
- , Paul M. Barr
- , Carolyn Owen
- , Osnat Bairey
- , Jan Burger
- , Cathy Zhou
- , Lori Styles
- , Danelle F. James
- , Thomas J. Kipps
Research output: Contribution to journal › Letter › peer-review
5
Link opens in a new tab
Scopus
citations